Navigation Links
Bunge Reports Fourth Quarter Net Income of $245 Million
Date:2/7/2008

interest to investors. See the Additional Financial Information

section included in the tables attached to this press release for more

information.

(3) See Note 1 to the consolidated statements of income attached to this

press release for information on the calculation of diluted earnings

per share.

Overview

Alberto Weisser, Bunge's Chairman and Chief Executive Officer stated, "2007 was an outstanding year. Bunge leveraged its integrated, global

operations, leading positions in key markets and good teamwork to produce record results."

"In 2007, the agribusiness and fertilizer markets were characterized by improved structural conditions. Demand for Bunge's end products grew and farm economics in Brazil strengthened. Our risk management strategies performed well in a dynamic market, and we were well-positioned to serve customers during a period marked by significant supply dislocations.

"The conditions that made 2007 compelling should continue in 2008. The USDA forecasts higher global protein meal and vegetable oil demand, as well as strong demand for and trade in other agricultural commodities. Crop prices should remain high, promoting input purchases by farmers. Not all market forces are working in Bunge's favor, however. For example, the strong real will increase local costs in our Brazilian businesses, and higher input costs could pressure margins in fertilizer and edible oils during the year.

"We plan to build on our success by continuing to follow our strategy of investing for growth and efficiency in our core businesses and in complementary value chains. In 2007, we expanded our oilseed processing footprint and launched a regional consumer packaged oil brand in China. We also enhanced processing assets in the Americas and Europe, purchased our first sugarcane mill and established a joint venture with OCP, the Moroccan fertilizer manufacturer, which will provide our business
'/>"/>

SOURCE Bunge Limited
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20

Related biology technology :

1. Digirad Corporation Reports Financial Results for 2007 Fourth Quarter and Twelve Months
2. ThermoGenesis Corp. Reports 48 Percent Growth in Second Quarter Revenues Year Over Year
3. Senesco Technologies Reports on Results of Preclinical Multiple Myeloma Studies
4. Recent Research Reports and Near-Term Corporate Events
5. Tutogen Medical, Inc. Reports First Quarter Fiscal 2008 Financial Results
6. Thermo Fisher Scientific Reports Record 2007 Fourth Quarter Revenues and Operating Performance; Provides Guidance for 2008
7. Thoratec Reports 10 Percent Increase in Fiscal 2007 Revenues; Fourth Quarter Revenues Largest in Company History
8. Rochester Medical Reports 31% Increase in Branded Sales Resulting in 9% Overall Sales Growth for the First Quarter
9. Wyeth Reports Earnings Results for the 2007 Fourth Quarter and Full Year
10. CuraGen Reports Fourth Quarter and Year End 2007 Financial Results
11. Covance Reports Full-Year 2007 Revenue Growth Of 15.4% and Seventh Consecutive Year of EPS Growth in Excess of 20%
Post Your Comments:
*Name:
*Comment:
*Email: